RVLP Annual EBIT
-$48.60 M
+$29.91 M+38.10%
31 December 2022
Summary:
As of February 3, 2025, RVLP annual earnings before interest & taxes is -$48.60 million, with the most recent change of +$29.91 million (+38.10%) on December 31, 2022. During the last 3 years, it has risen by +$231.21 million (+82.63%).RVLP EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVLP Quarterly EBIT
-$20.84 M
-$16.67 M-398.80%
30 June 2023
Summary:
As of February 3, 2025, RVLP quarterly earnings before interest & taxes is -$20.84 million, with the most recent change of -$16.67 million (-398.80%) on June 30, 2023. Over the past year, it has dropped by -$9.99 million (-92.10%).RVLP Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVLP TTM EBIT
-$57.17 M
-$9.99 M-21.19%
30 June 2023
Summary:
As of February 3, 2025, RVLP TTM earnings before interest & taxes is -$57.17 million, with the most recent change of -$9.99 million (-21.19%) on June 30, 2023. Over the past year, it has increased by +$1.35 million (+2.30%).RVLP TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVLP EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +38.1% | -92.1% | +2.3% |
| 3 y3 years | +82.6% | -19.5% | +64.4% |
| 5 y5 years | +14.1% | -261.0% | +79.6% |
RVLP EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +485.9% | -261.0% | +510.1% |
RVL Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$20.84 M(+398.8%) | -$57.17 M(+21.2%) |
| Mar 2023 | - | -$4.18 M(-69.8%) | -$47.17 M(-1.4%) |
| Dec 2022 | -$48.60 M(-38.1%) | -$13.83 M(-24.5%) | -$47.86 M(-7.1%) |
| Sept 2022 | - | -$18.31 M(+68.8%) | -$51.54 M(-11.9%) |
| June 2022 | - | -$10.85 M(+123.0%) | -$58.51 M(-15.2%) |
| Mar 2022 | - | -$4.87 M(-72.2%) | -$69.04 M(-10.8%) |
| Dec 2021 | -$78.52 M(-13.4%) | -$17.51 M(-30.8%) | -$77.43 M(-30.8%) |
| Sept 2021 | - | -$25.29 M(+18.3%) | -$111.92 M(+31.4%) |
| June 2021 | - | -$21.38 M(+61.3%) | -$85.15 M(+4.8%) |
| Mar 2021 | - | -$13.26 M(-74.5%) | -$81.22 M(+23.0%) |
| Dec 2020 | -$90.70 M | -$51.99 M(-3617.9%) | -$66.02 M(+81.8%) |
| Sept 2020 | - | $1.48 M(-108.5%) | -$36.31 M(-77.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | -$17.45 M(-998.9%) | -$160.61 M(-41.6%) |
| Mar 2020 | - | $1.94 M(-108.7%) | -$274.93 M(-1.7%) |
| Dec 2019 | -$279.81 M(+185.9%) | -$22.28 M(-81.9%) | -$279.81 M(-23.4%) |
| Sept 2019 | - | -$122.82 M(-6.8%) | -$365.22 M(+49.3%) |
| June 2019 | - | -$131.76 M(+4381.8%) | -$244.57 M(+144.9%) |
| Mar 2019 | - | -$2.94 M(-97.3%) | -$99.85 M(+2.0%) |
| Dec 2018 | -$97.87 M(+73.0%) | -$107.70 M(+4870.1%) | -$97.87 M(+944.5%) |
| Sept 2018 | - | -$2.17 M(-116.7%) | -$9.37 M(-61.3%) |
| June 2018 | - | $12.95 M(-1449.4%) | -$24.22 M(-34.8%) |
| Mar 2018 | - | -$959.60 K(-95.0%) | -$37.17 M(+2.7%) |
| Dec 2017 | -$56.59 M(+77.5%) | -$19.19 M(+12.8%) | -$36.21 M(+112.8%) |
| Sept 2017 | - | -$17.02 M | -$17.02 M |
| Dec 2016 | -$31.88 M | - | - |
FAQ
- What is RVL Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for RVL Pharmaceuticals?
- What is RVL Pharmaceuticals annual EBIT year-on-year change?
- What is RVL Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for RVL Pharmaceuticals?
- What is RVL Pharmaceuticals quarterly EBIT year-on-year change?
- What is RVL Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for RVL Pharmaceuticals?
- What is RVL Pharmaceuticals TTM EBIT year-on-year change?
What is RVL Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of RVLP is -$48.60 M
What is the all time high annual EBIT for RVL Pharmaceuticals?
RVL Pharmaceuticals all-time high annual earnings before interest & taxes is -$8.29 M
What is RVL Pharmaceuticals annual EBIT year-on-year change?
Over the past year, RVLP annual earnings before interest & taxes has changed by +$29.91 M (+38.10%)
What is RVL Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of RVLP is -$20.84 M
What is the all time high quarterly EBIT for RVL Pharmaceuticals?
RVL Pharmaceuticals all-time high quarterly earnings before interest & taxes is $12.95 M
What is RVL Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, RVLP quarterly earnings before interest & taxes has changed by -$9.99 M (-92.10%)
What is RVL Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of RVLP is -$57.17 M
What is the all time high TTM EBIT for RVL Pharmaceuticals?
RVL Pharmaceuticals all-time high TTM earnings before interest & taxes is -$9.37 M
What is RVL Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, RVLP TTM earnings before interest & taxes has changed by +$1.35 M (+2.30%)